The purpose of this study was to expand access to buprenorphine using a mobile health care
system among marginalized populations with or at high risk for HIV and observe longitudinal
effects of treatment.
- HIV +
- At high risk for HIV (IV drug use, commercial sex worker, partner of HIV+)
- Mental Health (unmanaged or diagnosed mental illness)
- Benzodiazepine use
- Opiate use due to pain management issues only (present or past)